Drug Profile
Esuprone
Alternative Names: LU 43839Latest Information Update: 24 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott GmbH & Co. KG
- Developer Abbott GmbH & Co. KG; Abbott Laboratories
- Class Antidepressants; Coumarins; Small molecules
- Mechanism of Action Monoamine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 31 Dec 1996 Discontinued-II for Depression in Germany (Unknown route)